Barclays
STRM

Barclays’s Streamline Health Solutions STRM Stock Holding History

Barclays’s Portfolio STRM Stock Details STRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-1
Closed – – 7270
2018
Q1 		$0 Buy
+1
New +$26 ﹤0.01% 7321
2014
Q1 		– Sell
-60
Closed -$5K – 7709
2013
Q4 		$5K Buy
+60
New +$6.59K ﹤0.01% 7178
2013
Q3 		– Sell
-87
Closed -$9K – 7603
2013
Q2 		$9K Buy
+87
New +$8.52K ﹤0.01% 7180

Other funds holding STRM

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Algert Global San Francisco, California $6.65B AUM 53.68% 1-Year Est. Return
JIC
Johnson Investment Counsel Cincinnati, Ohio $12.4B AUM 17.21% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Barclays's STRM Position: Q2 2018 in Review

Barclays sold out of Streamline Health Solutions (STRM) in Q2 2018, closing a stake of 1 share.

Barclays first reported a position in STRM in Q2 2013 and held it in 3 quarters. The position peaked at $9K in Q2 2013. 32 funds tracked by Wall St. Rank hold STRM as of Q2 2018.

  • Barclays reported no remaining Streamline Health Solutions position as of Q2 2018 after selling out during the quarter.
  • Barclays sold 1 Streamline Health Solutions share in Q2 2018.
  • Barclays first reported a position in Streamline Health Solutions in Q2 2013 and held it in 3 quarters.
  • Barclays's Streamline Health Solutions position peaked at $9K in Q2 2013.
  • 32 funds tracked by Wall St. Rank held Streamline Health Solutions as of Q2 2018.

Based on Barclays's 13F filing for Q2 2018, filed 14 Aug 2018.